You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent squamous cell carcinoma of the lip and oral cavity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
Has Results
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +26 more
  • Biopsy
  • +5 more
  • Newark, Delaware
  • +52 more
Feb 2, 2023

Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • +4 more
  • Near Infrared Imaging
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 5, 2022

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA

Withdrawn
  • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
  • +6 more
  • hypofractionated radiation therapy
  • +3 more
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell

Completed
Has Results
  • Stage IV Squamous Cell Carcinoma of the Hypopharynx
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 11, 2021

Oral Cavity Squamous Cell Carcinoma Trial in San Francisco (NisinZ® P, Surgery (non-interventional, standard of care))

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • NisinZ® P
  • Surgery (non-interventional, standard of care)
  • San Francisco, California
    University of California, San Francisco
Oct 18, 2023

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +21 more
  • Atezolizumab
  • +8 more
  • Little Rock, Arkansas
  • +97 more
Jan 27, 2023

Oral Cavity Squamous Cell Carcinoma Trial in Yichang (Sintilimab, Radiotherapy)

Recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • Yichang, Hubei, China
    Department of Medical Oncology, Central Hospital of Yichang City
Feb 18, 2023

Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

Recruiting
  • Squamous Cell Carcinoma of Oral Cavity
  • +3 more
  • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
  • Gliwice, Silesia, Poland
    The Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023

WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA

Recruiting
  • Oral Cancer
  • +2 more
  • Biopsy Specimens Histopathology
  • Rawalpindi, Punjab, Pakistan
    Armed Forces Institute of Pathology
Jun 22, 2023

Oral Squamous Cell Carcinoma, Maxillo-facial Surgery, Biomarkers Trial in Amiens (saliva tube)

Recruiting
  • Oral Squamous Cell Carcinoma
  • +5 more
  • saliva tube
  • Amiens, Picardie, France
    Amiens University Hospital
Mar 17, 2023

Squamous Cell Carcinoma of the Oral Cavity Trial in Rouen (Circulating tumor DNA detection)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • Circulating tumor DNA detection
  • Rouen, France
  • +1 more
Jun 29, 2023

T1 Squamous Cell Carcinomas of the Lip

Active, not recruiting
  • Lip
  • +9 more
    • Nijmegen, Gelderland, Netherlands
    • +2 more
    Nov 2, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Hangzhou, Zhejiang, China
      Department of Medical Onocology, First Affiliated Hospital of Zh
    Oct 7, 2023

    Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

    Active, not recruiting
    Has Results
    • Squamous Cell Carcinoma of the Oropharynx
    • +7 more
    • Tampa, Florida
    • +2 more
    Dec 30, 2022

    Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)

    Not yet recruiting
    • Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
    • Black Raspberry
    • (no location specified)
    Oct 16, 2023

    Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

    Recruiting
    • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +28 more
    • San Francisco, California
      University of California, San Francisco
    Dec 16, 2022

    Oral Squamous Cell Carcinoma Trial in Shanghai (Camrelizumab Plus Docetaxel and Cisplatin)

    Recruiting
    • Oral Squamous Cell Carcinoma
    • Camrelizumab Plus Docetaxel and Cisplatin
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Ton
    Nov 9, 2022

    Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous

    Recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • Guangzhou, Guangdong, China
      Liuxiqiang
    Feb 1, 2023

    Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)

    Not yet recruiting
    • Squamous Cell Carcinoma
    • Oral Cavity Squamous Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 27, 2023

    Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous

    Recruiting
    • Recurrent Head and Neck Squamous Cell Carcinoma
    • +5 more
    • Efineptakin alfa
    • San Francisco, California
      University of California San Francisco
    Jul 7, 2022

    Oral Cavity Squamous Cell Carcinoma Trial in Leuven (Durvalumab, Durvalumab + Tremelimumab)

    Active, not recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • Leuven, Belgium
      UZ Leuven
    May 30, 2022